ADEL K EL-NAGGAR to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.175
-
p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci U S A. 2006 Dec 26; 103(52):19842-7.
Score: 0.065
-
Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol. 2003 Feb; 22(2):409-14.
Score: 0.050
-
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer. 1998 Jun 01; 82(11):2159-65.
Score: 0.036
-
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell. 2012 Jun 12; 21(6):793-806.
Score: 0.024